Journal article
Impact of Metabolic Syndrome and Diabetes on Prognosis and Outcomes With Early Percutaneous Coronary Intervention in the COURAGE (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Trial
Abstract
OBJECTIVES: Our purpose was to clarify the clinical utility of identifying metabolic syndrome (MetS) in patients with coronary artery disease (CAD).
BACKGROUND: It is uncertain whether MetS influences prognosis in patients with CAD and whether the risk associated with MetS exceeds the risk associated with the sum of its individual components.
Authors
Maron DJ; Boden WE; Spertus JA; Hartigan PM; Mancini GBJ; Sedlis SP; Kostuk WJ; Chaitman BR; Shaw LJ; Berman DS
Journal
Journal of the American College of Cardiology, Vol. 58, No. 2, pp. 131–137
Publisher
Elsevier
Publication Date
July 2011
DOI
10.1016/j.jacc.2011.02.046
ISSN
0735-1097